The DOI matches its Crossref record; 160 of the 163 references it cites were found in a registry or an index.
Neurological phenotypes for Down syndrome across the life span
Open accessAbstract
This chapter reviews the neurological phenotype of Down syndrome (DS) in early development, childhood, and aging. Neuroanatomic abnormalities in DS are manifested as aberrations in gross brain structure as well as characteristic microdysgenetic changes. As the result of these morphological abnormalities, brain circuitry is impaired. While an intellectual disability is ubiquitous in DS, there is a wide range of variation in cognitive performance and a growing understanding between aberrant brain circuitry and the cognitive phenotype. Hypotonia is most marked at birth, affecting gait and ligamentous laxity. Seizures are bimodal in presentation with infantile spasms common in infancy and generalized seizures associated with cognitive decline observed in later years. While all individuals have the characteristic neuropathology of Alzheimer's disease (AD) by age 40 years, the prevalence of dementia is not universal. The tendency to develop AD is related, in part, to several genes on chromosome 21 that are overexpressed in DS. Intraneuronal accumulation of β-amyloid appears to trigger a cascade of neurodegeneration resulting in the neuropathological and clinical manifestations of dementia. Functional brain imaging has elucidated the temporal sequence of amyloid deposition and glucose metabolic rate in the development of dementia in DS. Mitochondrial abnormalities contribute to oxidative stress which is part of AD pathogenesis in DS as well as AD in the general population. A variety of medical comorbidities threaten cognitive performance including sleep apnea, abnormalities in thyroid metabolism, and behavioral disturbances. Mouse models for DS are providing a platform for the formulation of clinical trials with intervention targeted to synaptic plasticity, brain biochemistry, and morphological brain alterations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
People with Down syndrome often develop Alzheimer-like dementia at approximately 40 to 50 years of age.
“One striking characteristic of people with DS is that at approximately 40–50 years of age, AD-like dementia often appears59,60.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [59]
The Dementia section says that Alzheimer’s disease neuropathology is present in people with Down syndrome by age 40, and the Abstract says they have a tendency to develop dementia. But the paper distinguishes neuropathology from clinical dementia, whose prevalence it says is not universal; these passages do not establish that dementia often appears specifically at ages 40–50. (LLM, conf=0.86)
Experimental — accuracy not yet measuredBoth a dose effect from APP triplication and gene-environment interactions likely contribute to Alzheimer-like dementia in Down syndrome.
“It is likely that both a dose effect of triplication of APP and gene-environment interactions play a role59,60.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [59]
The Dementia section links increased APP gene dosage in Down syndrome to early β-amyloid deposition, supporting the APP-dose part of the claim. The introductory section says the neurological phenotype reflects genetic expression and environmental influences, but our copy does not specifically link gene–environment interactions to Alzheimer-like dementia. (LLM, conf=0.84)
Experimental — accuracy not yet measuredDown syndrome phenotypes result from full or partial triplication of chromosome 21.
“The varied phenotypes of DS result from full or partial triplication of chromosome 21, the most common human chromosomal disorder59.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [59]
The Dementia section links Down syndrome to trisomy 21 and overexpression of a chromosome 21 gene, while the Neuroanatomic abnormalities section discusses effects of an extra chromosome 21 on development. These passages support a chromosome 21 basis for Down syndrome phenotypes, but the copy does not establish that partial triplication of chromosome 21 produces the varied human phenotypes; its reference to partial trisomy concerns mice. (LLM, conf=0.82)
Experimental — accuracy not yet measuredOther chromosome 21-encoded proteins may be involved in Down syndrome, including Cu/Zn-superoxide dismutase and Bach1.
“Other proteins encoded on chromosome 21 may be involved59, such as Cu/Zn-superoxide dismutase (which is an important antioxidant enzyme normally, but can be deleterious if excess is present8) and Bach1 (transcriptional inhibitor of heme oxygenase-1, HO-1).”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [59]
The Dementia section (page not available in our copy) names superoxide dismutase among chromosome 21 genes implicated in Alzheimer’s disease pathology in Down syndrome. It does not mention Bach1 or describe its proposed role, so that example is unsupported by this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Andriolo, R. B., Dib, R. E., Ramos, L., Atallah, Á. N., & da Silva, E. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005176.pub3 · Cited by 10
RetractedCerebellum and nonmotor function
Strick, P. L., Dum, R. P., & Fiez, J. A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125606 · Cited by 1,777 · cited 1×
“It seems plausible that neuropsychological abnormalities in DS such as impaired attention, executive control, language learning, working memory, and emotional responses may reflect dysfunction in the cerebellar–cortical–limbic circuitry (Strick et al., 2009).”
BackgroundAmaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 2×
“…brain studies in autism have shown dysgenetic abnormalities in the frontal lobes, amygdala, and cerebellum—all areas that have been described as dysgenetic in DS. Recent reviews have suggested that the time course of brain development may be an important determining factor (Amaral et al., 2008).”
BackgroundSchmahmann, J. D. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.3.367 · Cited by 1,490 · cited 1×
“Beyond its effect on motor functioning, disorganized cerebellar output may impair higher order functioning such as emotion and cognition (Schmahmann, 2004; Teipel et al., 2004).”
BackgroundOccurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159 · cited 1×
“The characteristic neuropathology of AD is present in the brains of individuals with DS by age 40 years (Mann and Esiri, 1989; Wisniewski et al., 1985).”
BackgroundThe pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812
Hearing loss and cognition in the Baltimore Longitudinal Study of Aging.
Lin, F. R., Ferrucci, L., Metter, E. J., An, Y., Zonderman, A. B., & Resnick, S. M. (2011) · Neuropsychology · doi:10.1037/a0024238 · Cited by 696 · cited 1×
“Hearing loss in adults in the general population may be independently associated with lower test scores of memory and executive functioning (Gates et al., 2010; Lin et al., 2011).”
BackgroundAmyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
Rumble, B. A., Retallack, R. W., Hilbich, C., Simms, G., Multhaup, G., Martins, R. N., Hockey, A., Montgomery, P., Beyreuther, K. T., & Masters, C. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906013202203 · Cited by 656
Salehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543 · cited 1×
“In evaluation of the genes within the targeted chromosomal segment in Ts65Dn mice, it became apparent that an extra copy of the gene for APP contributed to decreased transport of nerve growth factor (Salehi et al., 2006).”
BackgroundCognitive deficits and associated neurological complications in individuals with Down's syndrome
Lott, I. T., & Dierssen, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70112-5 · Cited by 484 · cited 2×
“As recently reviewed (Lott and Dierssen, 2010), the cerebellum may be implicated in both cognition and affect in individuals with DS.”
BackgroundSelf-citationMann, D. M. A., & Esiri, M. M. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90019-1 · Cited by 471 · cited 1×
“The characteristic neuropathology of AD is present in the brains of individuals with DS by age 40 years (Mann and Esiri, 1989; Wisniewski et al., 1985).”
BackgroundThe Effect of Chronic or Intermittent Hypoxia on Cognition in Childhood: A Review of the Evidence
Bass, J. L., Corwin, M. J., Gozal, D., Moore, C., Nishida, H., Parker, S. J., Schonwald, A., Wilker, R. E., Stehle, S., & Kinane, T. B. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0227 · Cited by 452 · cited 1×
“There have been few studies of the cognitive consequences of obstructive sleep apnea in DS, but there is known to be an association of sleep apnea with lower IQ testing and behavioral difficulties (Bass et al., 2004; Melendres et al., 2004).”
BackgroundNeuroanatomy of Down’s Syndrome: A High-Resolution MRI Study
Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1659 · Cited by 452 · cited 2×
“Magnetic resonance imaging (MRI) studies show an approximate 17% decrease in children with DS between 10 and 20years (Pinter et al., 2001a).”
BackgroundDevelopmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448 · cited 1×
“The Ts65Dn mouse model of DS appears to parallel the cholinergic degeneration found in adults with DS and dementia which is correlated with deficient release of acetylcholine from the hippocampus (Holtzman et al., 1996).”
BackgroundDaytime Sleepiness and Hyperactivity in Children With Suspected Sleep-Disordered Breathing
Melendres, C., Lutz, J. M., Rubin, E. D., & Marcus, C. L. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0730 · Cited by 381 · cited 1×
“There have been few studies of the cognitive consequences of obstructive sleep apnea in DS, but there is known to be an association of sleep apnea with lower IQ testing and behavioral difficulties (Bass et al., 2004; Melendres et al., 2004).”
BackgroundDown's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
Baek, K., Zaslavsky, A., Lynch, R. C., Britt, C., Okada, Y., Siarey, R. J., Lensch, M. W., Park, I., Yoon, S. S., Minami, T., et al. (2009) · Nature · doi:10.1038/nature08062 · Cited by 375 · cited 1×
“However, other studies of subclinical hypothyroidism in the general population have failed to show significant neuropsychiatric problems (Baek et al., 2009).”
BackgroundCooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · cited 1×
“Basal forebrain cholinergic neuronal degeneration has been reversed by intracerebroventricular injections of nerve growth factor (Cooper et al., 2001).”
BackgroundWisniewski, K. E. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370755 · Cited by 297 · cited 1×
“The brain is brachycephalic with a small cerebellum, simplified gyral appearance, and a narrow superior temporal gyrus (Coyle et al., 1986; Wisniewski, 1990).”
BackgroundSelective neuroanatornic abnormalities in Down's syndrome and their cognitive correlates
Raz, N., Torres, I. J., Briggs, S. D., Spencer, W. D., Thornton, A. E., Loken, W. J., Gunning, F. M., McQuain, J., Driesen, N. R., & Acker, J. D. (1995) · Neurology · doi:10.1212/wnl.45.2.356 · Cited by 297 · cited 1×
“Ultrastructural studies show that synaptic density, synaptic length, and the contact zones between neurons are abnormal (Raz et al., 1995) (Fig.”
BackgroundCognitive profile and brain morphological changes in obstructive sleep apnea
Torelli, F., Moscufo, N., Garreffa, G., Placidi, F., Romigi, A., Zannino, S., Bozzali, M., Fasano, F., Giulietti, G., Djonlagic, I. E., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.065 · Cited by 296
Shott, S. R., Amin, R. S., Chini, B. A., Heubi, C. H., Hotze, S. L., & Akers, R. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.4.432 · Cited by 295 · cited 2×
“Obstructive sleep apnea occurs in over half of children with DS aged 2–4years and is related to otolaryngological problems associated with the disorder (Shott et al., 2006).”
BackgroundAlzheimer's disease in Down syndrome: Neurobiology and risk
Zigman, W. B., & Lott, I. T. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20163 · Cited by 290 · cited 2×
“Lack of balance in the metabolism of free radicals may have a direct role in the development of neuropathological changes of AD in DS (Zigman and Lott, 2007).”
BackgroundSelf-citationDYRK1A-mediated Hyperphosphorylation of Tau
Ryoo, S., Jeong, H. K., Radnaabazar, C., Yoo, J.-J., Cho, H.-J., Lee, H. W., Kim, I.-S., Cheon, Y. H., Ahn, Y. S., Chung, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707358200 · Cited by 285
Contestabile, A., Fila, T., Ceccarelli, C., Bonasoni, P., Bonapace, L., Santini, D., Bartesaghi, R., & Ciani, E. (2007) · Hippocampus · doi:10.1002/hipo.20308 · Cited by 281 · cited 2×
“An analysis of cell proteins expressed in various stages of the cell cycle has shown a prolongation of the G2 phase of the cell cycle, the last step in interphase prior to mitotic division (Contestabile et al., 2007).”
BackgroundMolecular genetic analysis of Down syndrome
Patterson, D. (2009) · Human Genetics · doi:10.1007/s00439-009-0696-8 · Cited by 278 · cited 2×
“…number of animals in a short time, genetic engineering for individual genes, control for genetic background, low cost of screening, ability to study both developing and mature subjects, modeling therapeutic interventions, and the lack of postmortem delays (Patterson, 2009; Salehi et al., 2007).”
BackgroundGuidi, S., Bonasoni, P., Ceccarelli, C., Santini, D., Gualtieri, F., Ciani, E., & Bartesaghi, R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00113.x · Cited by 276 · cited 1×
“In fetuses with DS, an analysis of cell phenotypes shows less reduction in astrocytes as compared to neurons (Guidi et al., 2008).”
BackgroundNoebels, J. L. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02909.x · Cited by 261 · cited 1×
“Seizures in the temporal lobe may damage hippocampal circuitry, a situation which is worsened by the toxic accumulation of amyloid-b peptides seen in Alzheimer’s disease (AD) (Noebels, 2011).”
BackgroundMégarbané, A., Ravel, A., Mircher, C., Sturtz, F. G., Grattau, Y., Rethoré, M. O., Delabar, J. M., & Mobley, W. C. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b2e34c · Cited by 261 · cited 1×
“This raises the prospect that treatment to reduce the level of APP gene expression may lessen the severity of cognitive decline in the dementia associated with DS (Megarbane et al., 2009).”
BackgroundPsychiatric and behavioral disorders in persons with Down syndrome
Dykens, E. M. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20159 · Cited by 258 · cited 2×
“age-matched peers, children with DS show higher rates of inattention, oppositional behaviors, and impulsivity (Dykens, 2007).”
BackgroundResultIntraneuronal Aβ42 accumulation in Down syndrome brain: Original Articles
Mori, C., Spooner, E. T., Wisniewski, K. E., Wisniewski, T. M., Yamaguchi, H., Saido, T. C., Tolan, D. R., Selkoe, D. J., & Lemere, C. A. (2002) · Amyloid · doi:10.3109/13506120208995241 · Cited by 255 · cited 1×
“Memory loss in old age is strongly correlated with a decline in the levels of acetylcholine (Mori et al., 2002; White and Ruske, 2002).”
BackgroundIntrinsic defect of the immune system in children with Down syndrome: a review
Kusters, M., Verstegen, R. H. J., Gemen, E. F. A., & de Vries, E. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03890.x · Cited by 252 · cited 1×
“Immune dysfunction in DS has been associated with the occurrence of AD (Kusters et al., 2009).”
BackgroundThe neurobiologie consequences of down syndrome
Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248 · cited 1×
“The brain is brachycephalic with a small cerebellum, simplified gyral appearance, and a narrow superior temporal gyrus (Coyle et al., 1986; Wisniewski, 1990).”
BackgroundGene expression profiling in the adult Down syndrome brain
Lockstone, H. E., Harris, L. W., Swatton, J. E., Wayland, M. T., Holland, A. J., & Bahn, S. (2007) · Genomics · doi:10.1016/j.ygeno.2007.08.005 · Cited by 240
Malformations of cortical development and epilepsy
Leventer, R. J., Guerrini, R., & Dobyns, W. B. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.1/rjleventer · Cited by 238
DiGuiseppi, C., Hepburn, S., Davis, J. M., Fidler, D. J., Hartway, S., Lee, N. R., Miller, L., Ruttenber, M., & Robinson, C. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181d5aa6d · Cited by 233 · cited 1×
“…may reflect an underlying problem in social interactions in some children with DS. Recent use of screening tools and standardized diagnostic measures in 123 children with DS has yielded a prevalence of 18% for autistic spectrum disorders and 7% for the diagnosis of autism (DiGuiseppi et al., 2010).”
BackgroundGreen Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Guedj, F., Sebrié, C., Rivals, I., Ledru, A., Paly, E., Bizot, J. C., Smith, D., Rubin, E. M., Gillet, B., Arbonés, M. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004606 · Cited by 227 · cited 1×
“In a study utilizing a polyphenol diet, the major features of the transgenic phenotype were rescued (Guedj et al., 2009).”
BackgroundImpaired thalamocortical connectivity in humans during general-anesthetic-induced unconsciousness
White, N. S., & Alkire, M. T. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00103-4 · Cited by 223 · cited 1×
“These anatomic findings have also been seen by voxel-based morphometric MRI studies of the brain in children and adults with DS (Pinter et al., 2001a,b; Teipel et al., 2003, 2004; White and Alkire, 2003).”
BackgroundMNB/DYRK1A as a multiple regulator of neuronal development
Tejedor, F. J., & Hämmerle, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07954.x · Cited by 214 · cited 1×
“Overexpression of DYRK1A may exert its effect on apoptosis and cell survival (Tejedor and Hammerle, 2011).”
BackgroundLeverenz, J. B., & Raskind, M. A. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6777 · Cited by 214 · cited 1×
“The parahippocampal and inferior temporal gyri demonstrate b-amyloid staining as young as 8years of age with subsequent accumulation in the CA-1/subiculum, dentate molecular layer, and the remainder of the hippocampal area (Leverenz and Raskind, 1998).”
BackgroundMartin, L. J. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816ff780 · Cited by 213 · cited 3×
“DNA damage, repair, and abnormal dynamic flux have been linked to oxidative stress and AD-type neurodegeneration (Martin, 2008; Vasudevaraju et al., 2008).”
Background(1991) · PubMed · Cited by 209
Cognition and daytime functioning in sleep-related breathing disorders
Jackson, M. L., Howard, M. E., & Barnes, M. (2011) · Progress in Brain Research · doi:10.1016/b978-0-444-53817-8.00003-7 · Cited by 202 · cited 1×
“Findings here show impaired working memory, attention, vigilance, and the ability to carry out simulated activities in the face of obstructive sleep apnea (Jackson et al., 2011).”
Background(1990) · PubMed · Cited by 201
Rammes, G., Rupprecht, R., Ferrari, U., Zieglgänsberger, W., & Parsons, C. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01872-9 · Cited by 200 · cited 1×
“The compound is also a noncompetitive inhibitor of the serotonin receptor 5HT3 (Rammes et al., 2001).”
BackgroundCognitive intervention in Alzheimer disease
Buschert, V. C., Bokde, A. L. W., & Hampel, H. J. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.113 · Cited by 197 · cited 1×
“Nonpharmacological interventions such as cognitive therapy and exercise have shown some improvements in individuals with AD within the general population (Buschert et al., 2010; Littbrand et al., 2011).”
BackgroundAmygdala and hippocampal volumes in children with Down syndrome: A high-resolution MRI study
Pinter, J. D., Brown, W. E., D, S. E. M., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · Neurology · doi:10.1212/wnl.56.7.972 · Cited by 197 · cited 2×
“Magnetic resonance imaging (MRI) studies show an approximate 17% decrease in children with DS between 10 and 20years (Pinter et al., 2001a).”
BackgroundDevelopment and validation of the Arizona Cognitive Test Battery for Down syndrome
Edgin, J. O., Mason, G. M., Allman, M. J., Capone, G. T., DeLeon, I. G., Maslen, C. L., Reeves, R. H., Sherman, S. L., & Nadel, L. (2010) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9054-3 · Cited by 194 · cited 2×
“Cognitive development in DS has been described elsewhere in this volume (Edgin et al., 2010a).”
BackgroundHealth Conditions Associated with Aging and End of Life of Adults with Down Syndrome
Esbensen, A. J. (2010) · International review of research in mental retardation · doi:10.1016/s0074-7750(10)39004-5 · Cited by 186 · cited 3×
“Individuals with DS are prone to develop hyperopia, strabismus, blepharitis, cataracts, and glaucoma (Esbensen, 2010; van Allen et al., 1999).”
BackgroundDown syndrome, Alzheimer’s disease and seizures
Menéndez, M. (2005) · Brain and Development · doi:10.1016/j.braindev.2004.07.008 · Cited by 186 · cited 1×
“Individuals with DS over age 45 years are more likely to develop dementia than those with seizures onset at younger ages (Menendez, 2005).”
BackgroundSimms, M. L., Kemper, T. L., Timbie, C. M., Bauman, M. L., & Blatt, G. J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0568-2 · Cited by 183 · cited 2×
“Moreover, careful morphological studies of postmortem brain of individuals with autism have shown subgroup variability in neuronal density, providing a cytoarchitectonic foundation for brain heterogeneity (Simms et al., 2009).”
BackgroundBrain Plasticity and Disease: A Matter of Inhibition
Baroncelli, L., Braschi, C., Spolidoro, M., Begenisic, T., Maffei, L., & Sale, A. (2011) · Neural Plasticity · doi:10.1155/2011/286073 · Cited by 173 · cited 1×
“Cortical-inhibition circuitries regulating neural plasticity has been postulated as related to the pathogenesis of brain functioning in both DS and autistic disorder (Baroncelli et al., 2011).”
BackgroundSeizure Disorders in Down Syndrome
Pueschel, S. M., Louis, S., & McKnight, P. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530150088024 · Cited by 172 · cited 1×
“The occurrence is bimodal with 40% having seizures before 1year of age—generally infantile spasms—and with 40% developing seizures after the third decade, generally tonic–clonic or myoclonic in manifestation (Pueschel et al., 1991).”
BackgroundBraudeau, J., Delatour, B., Duchon, A., Pereira, P. L., Dauphinot, L., de Chaumont, F., Olivo‐Marín, J., Dodd, R. H., Hérault, Y., & Potier, M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405366 · Cited by 172 · cited 1×
“Development of a GABA-A benzodiazepine receptor inverse agonist that is selective for the a5-subtype receptor appears to eliminate the convulsant propensity while maintaining cognitive restorative properties (Braudeau et al., 2011a,b).”
BackgroundGuidi, S., Ciani, E., Bonasoni, P., Santini, D., & Bartesaghi, R. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00459.x · Cited by 165 · cited 1×
“The anatomic locus for hypotonia in DS appears to be the cerebellum, a structure which shows hypocellularity due to impairment in the granular and periventricular zones during fetal development (Guidi et al., 2011).”
BackgroundStores, R., Stores, G., FELLOWS, B. J., & Buckley, S. (1998) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.1998.00123.x · Cited by 162 · cited 1×
“Children with DS may be at a lower risk for significant behavioral comorbidities in that they show a lower profile of maladaptive behaviors compared to children with other intellectual disabilities (Dykens and Kasari, 1997; Stores et al., 1998).”
BackgroundCoskun, P. E., Wyrembak, J., Derbereva, O., Melkonian, G., Doran, E. W., Lott, I. T., Head, E., Cotman, C. W., & Wallace, D. C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100351 · Cited by 161 · cited 1×
“Mitochondrial control region mutations are seen in the brains of individuals with DS and dementia as well as AD (Coskun et al., 2010) (Fig.”
BackgroundSelf-citationEvidence for a Specific Defect in Hippocampal Memory in Overt and Subclinical Hypothyroidism
Correia, N., Mullally, S. L., Cooke, G. E., Tun, T. K., Phelan, N., Feeney, J. C., Fitzgibbon, M. C., Boran, G. P., O’Mara, S. M., & Gibney, J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2702 · Cited by 158 · cited 1×
“The impairments resulting from hypothyroidism are primarily mnemonic rather than a reflection of general cognitive slowing and suggest a disruption of normal hippocampal function or connectivity (Correia et al., 2009).”
BackgroundFocal cortical dysplasia type II: biological features and clinical perspectives
Sisodiya, S. M., Fauser, S., Cross, J. H., & Thom, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70201-7 · Cited by 155 · cited 2×
“…to the areas of brain dysgenesis that are commonly part of the neuroanatomic presentation in DS. Areas of focal cortical dysplasia may be associated with epilepsy in the general population related to the location and size of the lesions (Andrade, 2009; Leventer et al., 2008; Sisodiya et al., 2009).”
BackgroundTeipel, S. J., Alexander, G. E., Schapiro, M. B., Möller, H., Rapoport, S. I., & Hampel, H. J. (2004) · Brain · doi:10.1093/brain/awh101 · Cited by 154 · cited 2×
“These anatomic findings have also been seen by voxel-based morphometric MRI studies of the brain in children and adults with DS (Pinter et al., 2001a,b; Teipel et al., 2003, 2004; White and Alkire, 2003).”
BackgroundWhy Pleiotropic Interventions are Needed for Alzheimer's Disease
Frautschy, S. A., & Cole, G. M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8137-1 · Cited by 152 · cited 1×
“The challenge of therapeutic trials in DS is similar to those reviewed for AD in the general population for which pleiotropic interventions have been recommended (Frautschy and Cole, 2010).”
BackgroundMarvanová, M., Lakso, M., Pirhonen, J., Nawa, H., Wong, G., & Ċastrén, E. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1027 · Cited by 150 · cited 1×
“Memantine is an antagonist of N-methyl D-aspartate receptor and appears to exert a positive effect on cognitive function by reducing oxidative damage and upregulating brain-derived neurotrophic factor (Marvanova et al., 2001).”
BackgroundLittbrand, H., Stenvall, M., & Rosendahl, E. (2011) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e318214de26 · Cited by 147 · cited 1×
“Nonpharmacological interventions such as cognitive therapy and exercise have shown some improvements in individuals with AD within the general population (Buschert et al., 2010; Littbrand et al., 2011).”
BackgroundKesslak, J. P., Nagata, S. F., Lott, I., & Nalcioglu, O. (1994) · Neurology · doi:10.1212/wnl.44.6.1039 · Cited by 145 · cited 1×
“Unexplainably, the parahippocampal gyrus may be larger than normal in DS (Kesslak et al., 1994).”
BackgroundSelf-citationEpilepsy in children with Down syndrome
Arya, R., Kabra, M., & Gulati, S. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0415 · Cited by 144 · cited 2×
“It appears that children with DS have better seizure control compared to other patients with symptomatic infantile spasms, and early initiation of appropriate treatment may contribute to the prevention of late seizure development and better developmental outcome (Arya et al., 2011).”
BackgroundExecutive Dysfunction and Presbycusis in Older Persons With and Without Memory Loss and Dementia
Gates, G. A., Gibbons, L. E., McCurry, S. M., Crane, P. K., Feeney, M. P., & Larson, E. B. (2010) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181d748d7 · Cited by 143 · cited 1×
“Hearing loss in adults in the general population may be independently associated with lower test scores of memory and executive functioning (Gates et al., 2010; Lin et al., 2011).”
BackgroundResearch Review: Reading comprehension in developmental disorders of language and communication
Ricketts, J. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02438.x · Cited by 142 · cited 1×
“Difficulties in word recognition, oral language, nonverbal ability, and working memory may underline reading comprehension problems in both DS and autistic spectrum disorders (Ricketts, 2011).”
BackgroundAutism, Alzheimer disease, and fragile X
Sokol, D. K., Maloney, B., Long, J. M., Ray, B., & Lahiri, D. K. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166dc7 · Cited by 141 · cited 1×
“Treatment with glutamate receptor antagonists may help repress APP and serve as a therapeutic target for AD (Sokol et al., 2011).”
BackgroundGonzález‐Agüero, A., Vicente‐Rodríguez, G., Moreno, L. A., Guerra-Balic, M., Ara, I., & Casajús, J. A. (2010) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2010.01120.x · Cited by 134 · cited 1×
“The low levels of physical activity in DS result in a higher body mass index, lower levels of lean mass, and reduced bone mass-related parameters, which, in turn, may affect cardiovascular strength capacities (Gonzalez-Aguero et al., 2010).”
BackgroundAmyloid-β Toxicity and Tau Hyperphosphorylation are Linked Via RCAN1 in Alzheimer's Disease
Lloret, A., Badía, M.-C., Giraldo, E., Ermak, G., Alonso, M.-D., Pallardó, F. V., Davies, K. J. A., & Viña, J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110890 · Cited by 133 · cited 1×
“Oxidative stress may be a common pathogenetic mechanism across multiple genetic disorders including ataxia-telangiectasia, Fanconi anemia, Werner syndrome, and DS (Lloret et al., 2011).”
BackgroundMENTAL AND MOTOR DEVELOPMENT IN YOUNG MONGOL CHILDREN*
Carr, J. (1970) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1970.tb01116.x · Cited by 133 · cited 2×
“from hypotonia is associated with a delay in motor development (Carr, 1970; Melyn and White, 1973).”
BackgroundValenti, D., Manente, G. A., Moro, L., Marra, E., & Vacca, R. A. (2011) · Biochemical Journal · doi:10.1042/bj20101908 · Cited by 133 · cited 1×
“A complex I deficit has been described in mitochondria from skin fibroblasts in DS that produces free radicals associated with oxidative stress (Valenti et al., 2011).”
BackgroundInfantino, V., Castegna, A., Iacobazzi, F., Spera, I., Scala, I., Andria, G., & Iacobazzi, V. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.11.166 · Cited by 133 · cited 1×
“Methylation, which is a necessary event in mitochondrial functioning, is impaired in DS (Infantino et al., 2011).”
BackgroundPostural control in children, teenagers and adults with Down syndrome
Rigoldi, C., Galli, M., Mainardi, L. T., Crivellini, M., & Albertini, G. (2010) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2010.09.007 · Cited by 131 · cited 1×
“The hypotonia induces difficulty in postural control such that an individual with DS is focused on overcoming a lack of equilibrium compared to controls and this necessitates a different strategy in motor development (Rigoldi et al., 2011).”
BackgroundDown syndrome and beta-amyloid deposition
Head, E., & Lott, I. T. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200404000-00003 · Cited by 128 · cited 2×
“Other genes on chromosome 21 that have been implicated in the pathogenesis of AD include superoxide dismutase, Ets-2 transcription factors, DS critical region stress-inducible factor, b-site APP cleaving enzyme, and S100b and dual-specificity tyrosine phosphorylation-regulation kinase 1A (DYRK1A) (Head and Lott, 2004).”
BackgroundSelf-citationDrug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.022 · Cited by 127 · cited 1×
“An ongoing conundrum for the use of agents to improve cognitive functioning is the interaction of the drug with existing medication, an issue that has been explored in the neuropsychiatric literature and which can be addressed partially through preclinical studies (Wallace et al., 2011).”
BackgroundEdgin, J. O., Pennington, B. F., & Mervis, C. Β. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01278.x · Cited by 122 · cited 2×
“Cognitive development in DS has been described elsewhere in this volume (Edgin et al., 2010a).”
BackgroundProfiles and development of adaptive behavior in children with Down syndrome
Dykens, E. M., Hodapp, R. M., & Evans, D. W. (2006) · Down Syndrome Research and Practice · doi:10.3104/reprints.293 · Cited by 120 · cited 1×
“Weakness in language abilities of children with DS has been noted (Dykens et al., 2006; Fidler et al., 2005; Rondal et al., 2003).”
BackgroundPritchard, M. A., & Kola, I. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_20 · Cited by 118 · cited 1×
“This may be an example of the disruption of developmental timing and homeostasis that occurs in DS and possibly other examples of aneuploidy (Pritchard and Kola, 1999).”
BackgroundCleland, J., Wood, S. E., Hardcastle, W. J., Wishart, J. G., & Timmins, C. (2009) · International Journal of Language & Communication Disorders · doi:10.3109/13682820902745453 · Cited by 116 · cited 1×
“Cleland (Cleland et al., 2010) has challenged the stereotypical perception that individuals with DS are highly social and have excellent “people” skills.”
BackgroundShields, N., & Taylor, N. F. (2010) · Journal of physiotherapy · doi:10.1016/s1836-9553(10)70024-2 · Cited by 116 · cited 2×
“…aspects from strategies using mixed physical activity programs, well-conducted research examining long-term physical outcomes, adverse effects, psychosocial outcomes, and costs is required before informed practice decisions can be made (Andriolo et al., 2010; Shields and Taylor, 2010).”
BackgroundEndocrine and musculoskeletal abnormalities in patients with Down syndrome
Hawli, Y. M. A., Nasrallah, M., & Fuleihan, G. E. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.80 · Cited by 115 · cited 1×
“Hypotonia in DS is often associated with low levels of physical activity with the result of decreased bone mass accrual and predisposition to fractures (Hawli et al., 2009).”
BackgroundRelation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down’s Syndrome
Teipel, S. J., Schapiro, M. B., Alexander, G. E., Krasuski, J., Horwitz, B., Hoehne, C., Möller, H., Rapoport, S. I., & Hampel, H. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1870 · Cited by 113 · cited 1×
“These anatomic findings have also been seen by voxel-based morphometric MRI studies of the brain in children and adults with DS (Pinter et al., 2001a,b; Teipel et al., 2003, 2004; White and Alkire, 2003).”
BackgroundLewis, J. D., & Elman, J. L. (2007) · Developmental Science · doi:10.1111/j.1467-7687.2007.00634.x · Cited by 109 · cited 1×
“Put slightly differently, deviant growth trajectories in autism may lead to developmental disruption of established patterns of functional connectivity (Lewis and Elman, 2008).”
BackgroundEmotional Competence in Children With Down Syndrome: Negativity and Regulation
Jahromi, L. B., Gulsrud, A. C., & Kasari, C. L. (2008) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2008)113[32:ecicwd]2.0.co;2 · Cited by 104 · cited 1×
“Differences are cited in developing task-oriented strategies for problem solving and difficulties with goaldirected behaviors (Glenn et al., 2001; Jahromi et al., 2008; Kasari and Freeman, 2001; Wishart, 1993; Wishart and Manning, 1996).”
BackgroundThe use of mouse models to understand and improve cognitive deficits in Down syndrome
Das, I., & Reeves, R. H. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007716 · Cited by 103 · cited 4×
“There are many genes in the mouse that are orthologous to genes on human chromosome 21 (Das and Reeves, 2011).”
BackgroundInfluentialDierssen, M., & de Lagrán, M. M. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.319 · Cited by 97
Molecular changes in fetal Down syndrome brain
Engidawork, E., & Lübec, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01614.x · Cited by 96 · cited 1×
“This reduction in brain size appears in 4–5-month fetuses and progresses during the last 3months of gestation (Engidawork and Lubec, 2003; Guihard-Costa et al., 2006).”
BackgroundThe development of learning difliculties in children with Down's syndrome
Wishart, J. G. (1993) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1993.tb00882.x · Cited by 96 · cited 1×
“Differences are cited in developing task-oriented strategies for problem solving and difficulties with goaldirected behaviors (Glenn et al., 2001; Jahromi et al., 2008; Kasari and Freeman, 2001; Wishart, 1993; Wishart and Manning, 1996).”
BackgroundDown Syndrome and Dementia: Seizures and Cognitive Decline
Lott, I. T., Doran, E. W., Nguyen, V. Q., Tournay, A. E., Movsesyan, N., & Gillen, D. L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111613 · Cited by 95 · cited 1×
“Seizures appear to be associated with rapid cognitive decline in demented individuals with DS (Lott et al., 2012).”
BackgroundSelf-citationEarly Development of Stereotyped and Self-Injurious Behaviors: I. Incidence
Berkson, G., Tupa, M., & Sherman, L. (2001) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2001)106 · Cited by 95
Prevalence of Pervasive Developmental Disorder in Down’s Syndrome
Lowenthal, R., Paula, C. S., Schwartzman, J. S., Brunoni, D., & Mercadante, M. T. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-007-0374-4 · Cited by 94 · cited 1×
“This is over a 10-fold increase compared to the general population (Lowenthal et al., 2007).”
BackgroundDepression in Down Syndrome: A review of the literature
Walker, J. C., Došen, A., Buitelaar, J. K., & Janzing, J. (2011) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2011.02.010 · Cited by 94 · cited 1×
“While it has been thought that individuals with DS are more prone to depression than those with other forms of intellectual disability, a recent meta-review does not support the putative increased prevalence of depression in trisomy 21 (Walker et al., 2011).”
BackgroundMENTAL AND DEVELOPMENTAL MILESTONES OF NONINSTITUTIONALIZED DOWN'S SYNDROME CHILDREN
Melyn, M. A., & White, D. T. (1973) · PEDIATRICS · doi:10.1542/peds.52.4.542 · Cited by 93 · cited 1×
“The ligamentous laxity resulting from hypotonia is associated with a delay in motor development (Carr, 1970; Melyn and White, 1973).”
BackgroundKim, S.-J., Lee, J. H., Lee, D. Y., Jhoo, J. H., & Woo, J. I. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181e9b976 · Cited by 93 · cited 1×
“In patients with mild cognitive impairment in the general population, sleep apnea was associated with an increase in language dysfunction (Kim et al., 2011).”
BackgroundHead, E., Lott, I. T., Patterson, D. W., Doran, E. W., & Haier, R. J. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11110 · Cited by 91 · cited 1×
“Neurite sprouting has been seen in approximately the same areas by postmortem examination (Haier et al., 2003; Head et al., 2007).”
BackgroundSelf-citationLu, J., Esposito, G., Scuderi, C., Steardo, L., Delli-Bovi, L. C., Hecht, J. L., Dickinson, B. C., Chang, C. J., Mori, T., & Sheen, V. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022126 · Cited by 91 · cited 1×
“Dysregulated chromosome 21 genes in cortical neural progenitor cells from individuals with DS lead to elevated levels of S100b-induced radical oxygen species along with loss of the water channel aquaporin 4, causing an increase in programmed cell death (Lu et al., 2011).”
BackgroundSystemic and neurologic autoimmune disorders associated with seizures or epilepsy
Vincent, A. C., & Crino, P. B. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03030.x · Cited by 87 · cited 1×
“Histopathological brain lesions include gliosis, demyelination, spongiform transformation of neurons, and vasculitis involving venules (Vincent and Crino, 2011).”
BackgroundNon‐psychiatric health problems among psychiatric inpatients with intellectual disabilities
Charlot, L., Abend, S. L., Ravin, P., Mastis, K., Hunt, A., & Deutsch, C. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01294.x · Cited by 86 · cited 1×
“In a study of nonpsychiatric health factors leading to psychiatric decompensation in adults with DS, 40% were found to have a significant comorbid medical condition considered causal in the behavioral decline (Charlot et al., 2011).”
BackgroundBiometry of Face and Brain in Fetuses with Trisomy 21
Guihard-Costa, A.-M., Khung‐Savatovsky, S., Delbecque, K., Ménez, F., & Delezoide, A. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000190580.88391.9a · Cited by 85 · cited 1×
“This reduction in brain size appears in 4–5-month fetuses and progresses during the last 3months of gestation (Engidawork and Lubec, 2003; Guihard-Costa et al., 2006).”
BackgroundDonepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10–17
Kishnani, P. S., Heller, J. H., Spiridigliozzi, G. A., Lott, I. T., Escobar, L., Richardson, S., Zhang, R. H., & McRae, T. D. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33730 · Cited by 83 · cited 1×
“Likewise, a trial of donepezil in children and adolescents with DS failed to demonstrate cognitive benefit (Kishnani et al., 2010).”
BackgroundSelf-citationTsao, R., & Kindelberger, C. (2008) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2008.10.009 · Cited by 79 · cited 1×
“The precise effect of the above-described cytoarchitectonic abnormalities on cognitive development in DS is not clear, in part due to individual variation in performance measures with age (Couzens et al., 2011; Tsao and Kindelberger, 2009).”
BackgroundCognitive status in Down syndrome individuals with sleep disordered breathing deficits (SDB)
Ανδρέου, Γ., Galanopoulou, C., Gourgoulianis, K., Karapetsas, A. B., & Molyvdas, P. A. (2002) · Brain and Cognition · doi:10.1016/s0278-2626(02)00019-2 · Cited by 79 · cited 1×
“In a small study of children with DS, sleep apnea was associated with difficulties in visual-perceptual skills involving the right hemisphere (Andreou et al., 2002).”
BackgroundChange in plasma Aβ peptides and onset of dementia in adults with Down syndrome
Schupf, N., Zigman, W. B., Tang, M. X., Pang, D. I., Mayeux, R. P., Mehta, P. D., & Silverman, W. P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fb448b · Cited by 78 · cited 2×
“indicators of conversion to AD, possibly reflecting compartmentalization of b-amyloid peptides in the brain (Schupf et al., 2010).”
BackgroundInfluentialÇeti̇ner, S., Demırhan, O., İnal, T. C., Korkmaz, D. T., & Sertdemır, Y. (2010) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2010.00914.x · Cited by 75 · cited 1×
“The immune dysfunction begins in children with DS as reflected in abnormalities seen on the analysis of peripheral T-cell subsets, natural killer cells, and serum cytokines (Cetiner et al., 2010).”
BackgroundHead, E., Doran, E. W., Nistor, M., HILL, M., Schmitt, F. A., Haier, R. J., & Lott, I. T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101335 · Cited by 73 · cited 1×
“After controlling for level of intellectual disability (mild, moderate, severe) and the presence or absence of dementia, there was an improved prediction of neuropsychological scores by plasma levels of b-amyloid (Head et al., 2011).”
BackgroundSelf-citationCouzens, D., Cuskelly, M., & Haynes, M. A. (2011) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-116.3.181 · Cited by 72 · cited 1×
“The precise effect of the above-described cytoarchitectonic abnormalities on cognitive development in DS is not clear, in part due to individual variation in performance measures with age (Couzens et al., 2011; Tsao and Kindelberger, 2009).”
BackgroundPositron Emission Tomography of Brain β-Amyloid and Tau Levels in Adults With Down Syndrome
Nelson, L. D., Siddarth, P., Kepe, V., Scheibel, K. E., Huang, S. C., Barrio, J. R., & Small, G. W. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.104 · Cited by 72 · cited 1×
“Measures of behavioral dysfunction in the same study are consistent with age-related progression of AD neuropathology in this population (Nelson et al., 2011).”
ResultTemporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
Haier, R. J., Alkire, M. T., White, N. S., Uncapher, M. R., Head, E., Lott, I. T., & Cotman, C. W. (2003) · Neurology · doi:10.1212/01.wnl.0000098935.36984.25 · Cited by 71 · cited 1×
“Neurite sprouting has been seen in approximately the same areas by postmortem examination (Haier et al., 2003; Head et al., 2007).”
BackgroundSelf-citationUsing mouse models to explore genotype–phenotype relationship in Down syndrome
Salehi, A., Faizi, M., Belichenko, P. V., & Mobley, W. C. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20164 · Cited by 70 · cited 2×
“…number of animals in a short time, genetic engineering for individual genes, control for genetic background, low cost of screening, ability to study both developing and mature subjects, modeling therapeutic interventions, and the lack of postmortem delays (Patterson, 2009; Salehi et al., 2007).”
BackgroundNeuropsychological correlates of word identification in Down syndrome
Fidler, D. J., Most, D. E., & Guiberson, M. (2005) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2004.11.007 · Cited by 70 · cited 1×
“Weakness in language abilities of children with DS has been noted (Dykens et al., 2006; Fidler et al., 2005; Rondal et al., 2003).”
BackgroundMerrick, J., Ezra, E., Josef, B., Hendel, D., Steinberg, D. M., & Wientroub, S. (2000) · Journal of Pediatric Orthopaedics B · doi:10.1097/01202412-200006000-00008 · Cited by 69 · cited 1×
“In individuals with DS, the excessive laxity of the posterior transverse ligament which attaches the odontoid bone to C1 appears to be the most common cause of atlanto-axial subluxation although there is no universal agreement on this point (Merrick et al., 2000).”
BackgroundMemory deficits in Alzheimer's disease: The encoding hypothesis and cholinergic function
White, K. G., & Ruske, A. C. (2002) · Psychonomic Bulletin & Review · doi:10.3758/bf03196301 · Cited by 69 · cited 1×
“Memory loss in old age is strongly correlated with a decline in the levels of acetylcholine (Mori et al., 2002; White and Ruske, 2002).”
BackgroundSimone, R. D., Salas‐Puig, X., Gélisse, P., Crespel, A., & Genton, P. (2010) · Seizure · doi:10.1016/j.seizure.2010.04.008 · Cited by 69 · cited 1×
“Senile myoclonic epilepsy appears to be a common manifestation of dementia in DS (De Simone et al., 2010).”
BackgroundAndriolo, R. B., Dib, R. E., Ramos, L., Atallah, Á. N., & da Silva, E. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005176.pub4 · Cited by 68 · cited 1×
“…aspects from strategies using mixed physical activity programs, well-conducted research examining long-term physical outcomes, adverse effects, psychosocial outcomes, and costs is required before informed practice decisions can be made (Andriolo et al., 2010; Shields and Taylor, 2010).”
BackgroundTreated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study
Kramer, C. K., von Mühlen, D. G., Kritz‐Silverstein, D. C., & Barrett-Connor, E. L. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0606 · Cited by 68 · cited 1×
“In subclinical and overt hypothyroidism in the general population, deficits are noted in spatial, associative, and verbal memory with some amelioration by thyroid replacement therapy (Kramer et al., 2009).”
BackgroundLandt, J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.36 · Cited by 65 · cited 1×
“4b) (Landt et al., 2011).”
Oxidative stress and cognitive ability in adults with Down syndrome
Strydom, A., Dickinson, M. J., Shende, S., Praticò, D., & Walker, Z. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.006 · Cited by 62 · cited 1×
“Multiple genes that are upregulated in trisomy 21 may contribute to transcriptional disruption and increase the liability to oxidative stress (Lockstone et al., 2007; Strydom et al., 2009).”
BackgroundEvaluation of memantine for the treatment of Alzheimer’s disease
Ferris, S. H. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.12.2305 · Cited by 60 · cited 1×
“In the general population, the drug appears to alleviate some symptoms of AD (Ferris, 2003).”
BackgroundBraudeau, J., Dauphinot, L., Duchon, A., Loistron, A., Dodd, R. H., Hérault, Y., Delatour, B., & Potier, M. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/153218 · Cited by 60 · cited 1×
“Development of a GABA-A benzodiazepine receptor inverse agonist that is selective for the a5-subtype receptor appears to eliminate the convulsant propensity while maintaining cognitive restorative properties (Braudeau et al., 2011a,b).”
BackgroundAndrade, D. M. (2009) · Human Genetics · doi:10.1007/s00439-009-0702-1 · Cited by 59 · cited 2×
“…to the areas of brain dysgenesis that are commonly part of the neuroanatomic presentation in DS. Areas of focal cortical dysplasia may be associated with epilepsy in the general population related to the location and size of the lesions (Andrade, 2009; Leventer et al., 2008; Sisodiya et al., 2009).”
BackgroundPatel, A., Rees, S. D., Kelly, M. A., Bain, S. C., Barnett, A. H., Thalitaya, D., & Prasher, V. P. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.010 · Cited by 59 · cited 1×
“There is an association of several biomarkers for AD for in the general population that are also seen in individuals with DS including APOE, SORL1, RUNX1, BACE1, and ALDH18a1 (Patel et al., 2011).”
BackgroundAlzheimer's Disease and Down Syndrome Rodent Models Exhibit Audiogenic Seizures
Westmark, C. J., Westmark, P. R., & Malter, J. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100087 · Cited by 58 · cited 1×
“These findings suggest that the amyloid precursor protein (APP), which is overexpressed in DS, may mediate this seizure susceptibility through the glutamate receptor (Westmark et al., 2009, 2010).”
BackgroundMolecular Dating of Senile Plaques in the Brains of Individuals with Down Syndrome and in Aged Dogs
Azizeh, B. Y., Head, E., Ibrahim, M. A., Torp, R., Tenner, A. J., Kim, R. C., Lott, I. T., & Cotman, C. W. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7359 · Cited by 58 · cited 1×
“Molecular dating techniques have shown that b-amyloid is deposited in the superficial layers of the frontal cortex in DS with subsequent transition to deeper cortical areas with age (Azizeh et al., 2000).”
Self-citationTrainee teachers’ attitudes to inclusive education for children with Down's syndrome
Wishart, J. G., & Manning, G. (1996) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1996.tb00603.x · Cited by 57 · cited 1×
“Differences are cited in developing task-oriented strategies for problem solving and difficulties with goaldirected behaviors (Glenn et al., 2001; Jahromi et al., 2008; Kasari and Freeman, 2001; Wishart, 1993; Wishart and Manning, 1996).”
BackgroundEngineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations
Toiber, D., Azkona, G., Ben‐Ari, S., Torán, N., Soreq, H., & Dierssen, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.011 · Cited by 55 · cited 1×
“Individuals with DS and mice with partial trisomy contain an extra copy of the DYRK1A gene and this appears to be associated with changes in brain morphogenesis (Dierssen and de Lagran, 2006; Toiber et al., 2010).”
BackgroundDonepezil for dementia in people with Down syndrome
Mohan, M., Carpenter, P. K., & Bennett, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007178.pub2 · Cited by 54 · cited 1×
“However, in DS, there appears to be no consistent or compelling evidence for efficacy of acetylcholinesterase inhibitors including donepezil, galantamine, and rivastigmine in preventing the cognitive decline associated with dementia (Mohan et al., 2009a–d).”
BackgroundMemory Profiles of Down, Williams, and Fragile X Syndromes: Implications for Reading Development
Conners, F. A., Moore, M. S., Loveall, S. J., & Merrill, E. C. (2011) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3182168f95 · Cited by 53 · cited 1×
“Children with DS appear to present memory profiles that are distinct from other Williams and fragile-X syndromes in that DS is characterized by good immediate visual memory and rapid phonological retrieval with poor verbal working memory skills (Conners et al., 2011; Edgin et al., 2010b).”
BackgroundEconomy and Preferred Speed of Walking in Adults with and Without Down Syndrome
Agiovlasitis, S., McCubbin, J. A., Yun, J., Pavol, M. J., & Widrick, J. J. (2009) · Adapted Physical Activity Quarterly · doi:10.1123/apaq.26.2.118 · Cited by 53 · cited 2×
“Infants with DS show a sequence of motor development similar to typically developing toddlers but a lower rate of motor milestone acquisition (Agiovlasitis et al., 2009).”
BackgroundHashimoto’s Thyroiditis in Down’s Syndrome: Clinical Presentation and Evolution
Popova, G., Paterson, W. F., Brown, A., & Donaldson, M. (2008) · Hormone Research in Paediatrics · doi:10.1159/000157874 · Cited by 49 · cited 1×
“Hashimoto’s encephalopathy, an autoimmune complication of hypothyroidism, which presents with myoclonus, neuropsychiatric symptoms, cognitive decline, and stroke-like episodes, has been described in DS (Brodtmann, 2009; Popova et al., 2008).”
BackgroundClinical and EEG Features of Epilepsy in Children and Adolescents in Down Syndrome
Śmigielska–Kuzia, J., Sobaniec, W., Kułąk, W., & Boćkowski, L. (2009) · Journal of Child Neurology · doi:10.1177/0883073808324542 · Cited by 48 · cited 1×
“There is a high rate of EEG abnormalities in DS without the recognition of clinical seizures (40%); therefore, EEG findings do not correlate with outcome (Smigielska-Kuzia et al., 2009).”
BackgroundChang, Q., & Gold, P. E. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.05.007 · Cited by 47 · cited 1×
“An encouraging aspect of the mouse study was the reversal of deficits in the 4-month-old Ts65Dn mouse when treated with an acetylcholinesterase inhibitor (Chang and Gold, 2008).”
BackgroundLennox‐Gastaut syndrome with late‐onset and prominent reflex seizures in trisomy 21 patients
Ferlazzo, E., Adjien, C. K., Guerrini, R., Calarese, T., Crespel, A., Elia, M., Striano, P., Gélisse, P., Bramanti, P., Bella, P. D., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01944.x · Cited by 47 · cited 1×
“When Lennox–Gastaut syndrome occurs in DS, the onset is usually later than seen in the typical population and may be associated with reflex seizures (Ferlazzo et al., 2009).”
BackgroundMemantine for dementia in people with Down syndrome.
Mohan, M., Bennett, C., & Carpenter, P. K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007657 · Cited by 46 · cited 1×
“However, in DS, there appears to be no consistent or compelling evidence for efficacy of acetylcholinesterase inhibitors including donepezil, galantamine, and rivastigmine in preventing the cognitive decline associated with dementia (Mohan et al., 2009a–d).”
BackgroundCosta, A. C. S. (2011) · Developmental Neuroscience · doi:10.1159/000330861 · Cited by 44 · cited 1×
“These findings have been translated into a clinical trial of memantine for improving cognitive functioning in young adults with DS which is currently underway (Costa, 2011).”
BackgroundRivastigmine for dementia in people with Down syndrome
Mohan, M., Bennett, C., & Carpenter, P. K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007658 · Cited by 43 · cited 1×
“However, in DS, there appears to be no consistent or compelling evidence for efficacy of acetylcholinesterase inhibitors including donepezil, galantamine, and rivastigmine in preventing the cognitive decline associated with dementia (Mohan et al., 2009a–d).”
BackgroundRueda, N., Flórez, J., & Martínez‐Cué, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.020 · Cited by 42 · cited 1×
“In the Ts65Dn mouse, oral treatment with memantine improved spatial learning in the Morris water maze task (Rueda et al., 2008).”
MethodGalantamine for dementia in people with Down syndrome
Mohan, M., Bennett, C., & Carpenter, P. K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007656 · Cited by 40 · cited 1×
“However, in DS, there appears to be no consistent or compelling evidence for efficacy of acetylcholinesterase inhibitors including donepezil, galantamine, and rivastigmine in preventing the cognitive decline associated with dementia (Mohan et al., 2009a–d).”
BackgroundDoes nicotine improve cognitive function?
Rusted, J. M., Graupner, L., O'Connell, N., & Nicholls, C. (1994) · Psychopharmacology · doi:10.1007/bf02245580 · Cited by 39 · cited 1×
“Administration of drugs that inhibit the breakdown of acetylcholine (donepezil) has reversed the memory deficits associated with aging and AD in the general population (Rusted et al., 1994; van Reekum et al., 1997).”
BackgroundRole of DNA dynamics in Alzheimer's disease
Vasudevaraju, P., ..., B., Garruto, R. M., Sambamurti, K., & Rao, K. S. J. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.01.001 · Cited by 37 · cited 2×
“DNA damage, repair, and abnormal dynamic flux have been linked to oxidative stress and AD-type neurodegeneration (Martin, 2008; Vasudevaraju et al., 2008).”
BackgroundMastery motivation in children with Down syndrome
Glenn, S. M., Dayus, B., Cunningham, C., & Horgan, M. F. (2001) · Down Syndrome Research and Practice · doi:10.3104/reports.114 · Cited by 37 · cited 1×
“Differences are cited in developing task-oriented strategies for problem solving and difficulties with goaldirected behaviors (Glenn et al., 2001; Jahromi et al., 2008; Kasari and Freeman, 2001; Wishart, 1993; Wishart and Manning, 1996).”
BackgroundUrinary uric acid and antioxidant capacity in children and adults with Down syndrome
Campos, C., Guzmán, R., López-Fernández, E., & Casado, Á. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.09.017 · Cited by 36 · cited 1×
“Urinary markers of oxidative stress are increased in adolescents and adults with DS (Campos et al., 2010).”
BackgroundRecognition and management of childhood cancer syndromes: A systems approach
Clericuzio, C. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990625)89:2 · Cited by 34
Specific grasp characteristics of children with trisomy 21
Jover, M., Ayoun, C., Berton, C., & Carlier, M. (2010) · Developmental Psychobiology · doi:10.1002/dev.20474 · Cited by 34 · cited 1×
“The instability in trunk control may be linked to atypical finger grasping patterns (Jover et al., 2010).”
BackgroundAmyloid β concentrations in older people with Down syndrome and dementia
Jones, E. L., Hanney, M., Francis, P. T., & Ballard, C. G. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.12.030 · Cited by 33 · cited 4×
“However, in demented adults with DS, APOE4 allele was associated with higher Ab40 but not Ab42.”
BackgroundInfluentialUse of health care guidelines in patients with Down syndrome by family physicians across Canada
Virji‐Babul, N., Eichmann, A., Kisly, D., Down, J., & Haslam, R. H. A. (2007) · Paediatrics & Child Health · doi:10.1093/pch/12.3.179 · Cited by 30 · cited 2×
“Evaluation of thyroid functioning has been a part of health care guidelines for both children and adults with DS (Virji-Babul et al., 2007).”
BackgroundCognition-enhancing drugs in dementia: a guide to the near future.
van Reekum, R., Black, S. E., Conn, D. K., & Clarke, D. E. (1997) · PubMed · Cited by 30
Epilepsy in adult patients with Down syndrome: a clinical‐video EEG study
Vignoli, A., Zambrelli, E., Chiesa, V., Savini, M. N., Briola, F. L., Gardella, E., & Canevini, M. P. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0426 · Cited by 30 · cited 2×
“Electroclinical characteristics of seizures in adults with DS have included progressive slowing of background activity with frontal sharp and slow waves while those with myoclonic epilepsy typically display generalized spike and slow wave discharges (Vignoli et al., 2011).”
BackgroundMPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta.
Westmark, C. J., Westmark, P. R., & Malter, J. S. (2009) · PubMed Central · Cited by 29
Adaptive behaviour in Down syndrome: a cross-sectional study from childhood to adulthood
Dressler, A., Perelli, V., Feucht, M., & Bargagna, S. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1504-0 · Cited by 28 · cited 1×
“Socialization and competence in daily living skills appear to improve through age 30years in DS (Dressler et al., 2010).”
BackgroundMelatonin and Elimination of Kynurenines in Children with Down's Syndrome
Uberos, J., Romero, J. L. C., Molina‐Carballo, A., & Muñoz‐Hoyos, A. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.23.3.277 · Cited by 26
Hashimoto Encephalopathy and Down Syndrome
Brodtmann, A. G. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.45 · Cited by 26 · cited 1×
“Hashimoto’s encephalopathy, an autoimmune complication of hypothyroidism, which presents with myoclonus, neuropsychiatric symptoms, cognitive decline, and stroke-like episodes, has been described in DS (Brodtmann, 2009; Popova et al., 2008).”
Backgroundβ-Amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome
Head, E., Lott, I. T., Cribbs, D. H., Cotman, C. W., & Rohn, T. T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00705-x · Cited by 23 · cited 1×
“Caspase activation, another precursor of programmed cell death, occurs in association with amyloid plaques and neurofibrillary tangles in DS (Head et al., 2002).”
BackgroundSelf-citationGalli, M., Cimolin, V., Patti, P. J., Ferrario, D., Heaney, G., Albertini, G., & Freedland, R. L. (2010) · Disability and Rehabilitation · doi:10.3109/09638281003734367 · Cited by 23 · cited 1×
“In a quantitative movement protocol measuring functional mobility, individuals with DS appeared to show longer durations of execution across all of the standardized tasks (Galli et al., 2010).”
BackgroundInfantile spasms in children with Down syndrome.
Lujić, L., Bošnjak, V. M., Delin, S., Đuranović, V., & Krakar, G. (2011) · PubMed · Cited by 22
The effect of chlorimipramine on DNA synthesis and mitosis in cultured human cells.
Mittwoch, U., & Wilkie, D. R. (1971) · PubMed · Cited by 14
Okadaic acid induces apoptosis in Down syndrome fibroblasts
Dogliotti, G., Galliera, E., Dozio, E., Vianello, E., Villa, R. E., Licastro, F., Barajon, I., & Romanelli, M. M. C. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.12.012 · Cited by 11 · cited 1×
“…carbon 11-labeled Pittsburgh Compound B or a subject with DS and AD (top) and a control without DS Neurology, Nelson LD et al., Positron emission tomogrpahy , 2011, June; 68(6):768–774 with permission from American S, old DS, and AD showing binding characteristics. lines (Dogliotti et al., 2010).”
BackgroundJi, L., Chauhan, V. P. S., Mehta, P. D., Węgiel, J., Mehta, S. P., & Chauhan, A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101029 · Cited by 10 · cited 1×
“An alternative explanation may relate to the DYRK1A which is located on chromosome 21 and regulates multiple genes that may contribute to deregulation of neural pathways responsible for dementia (Ji et al., 2010).”
BackgroundKemper, T. L. (1991) · Cerebral cortex · doi:10.1007/978-1-4615-6622-9_12 · Cited by 9
Françoise, a fifteen year follow up
Rondal, J. A., Elbouz, M., Ylieff, M., & Docquier, L. (2002) · Down Syndrome Research and Practice · doi:10.3104/case-studies.135 · Cited by 8 · cited 1×
“Weakness in language abilities of children with DS has been noted (Dykens et al., 2006; Fidler et al., 2005; Rondal et al., 2003).”
BackgroundGlidden, L. M., & Floyd, F. J. (1997) · American Journal on Mental Retardation · doi:10.1352/0895-8017(1997)102
Flagged first, then by citations
3 of the 163 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
“At the age of 50, typical neuropathological hallmarks of AD appear in DS persons, including deposition of senile plaques containing amyloid β-peptide (Aβ), neurofibrillary tangles composed of hyperphosphorylated tau-P, and cholinergic and serotoninergic reduction (210).”
BackgroundDown syndrome: Cognitive and behavioral functioning across the lifespan
Grieco, J. A., Pulsifer, M., Seligsohn, K., Skotko, B. G., & Schwartz, A. (2015) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31439 · Cited by 483
Emerging connections between cerebellar development, behaviour and complex brain disorders
Sathyanesan, A., Zhou, J., Scafidi, J., Heck, D. H., Sillitoe, R. V., & Gallo, V. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0152-2 · Cited by 341
Down syndrome and the complexity of genome dosage imbalance
Antonarakis, S. E. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.154 · Cited by 314
Down syndrome and Alzheimer's disease: common pathways, common goals
Hartley, D., Blumenthal, T., Carrillo, M., DiPaolo, G., Esralew, L., Gardiner, K., Granholm, A.-C., Iqbal, K., Krams, M., Lemere, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.007 · Cited by 290
“Also, linking cognitive studies and functional imaging may allow prediction of cognitive impairment and provide a platform for early intervention [66].”
BackgroundSelf-citationMarzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2023) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 322
Cellular Senescence in Neurodegenerative Diseases
Martínez‐Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 299
“These cognitive alterations are due to defects in growth and differentiation of the CNS that appear during early prenatal stages (Haydar and Reeves, 2012; Lott, 2012).”
BackgroundDown syndrome: the brain in trisomic mode
Dierssen, M. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3314 · Cited by 288
Atypical aging in down syndrome
Zigman, W. B. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1128 · Cited by 262
Olmos-Serrano, J. L., Kang, H. J., Tyler, W. A., Silbereis, J. C., Cheng, F., Zhu, Y., Pletikos, M., Jankovic-Rapan, L., Cramer, N. P., Galdzicki, Z., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.042 · Cited by 239
“…analyses, because both regions have been implicated in DS neuropathology (Hartley et al., 2015; Haydar and Reeves, 2012; Letourneau et al., 2014; Lott, 2012) and exhibit diverse transcriptional profiles over the course 2 Neuron 89, 1–15, March 16, 2016 ª2016 Elsevier Inc. of development (Kang…”
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230
“This patient, although of extremely advanced age for a person with DS, especially without the characteristic changes of AD [70], showed no clinical signs of dementia, and magnetic resonance imaging (MRI) 6 months before her death showed only minimal cerebral atrophy and no temporal lobe atrophy.”
BackgroundValenti, D., Lidia de, B. A. R. I., Filippis, B. D., Henrion‐Caude, A., & Vacca, R. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.012 · Cited by 203
Human Models Are Needed for Studying Human Neurodevelopmental Disorders
Zhao, X., & Bhattacharyya, A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.009 · Cited by 192
Valenti, D., Rasmo, D. D., Signorile, A., Rossi, L., Lidia de, B. A. R. I., Scala, I., Granese, B., Papa, S., & Vacca, R. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.011 · Cited by 144
“Individuals with DS show an early aging associated with a decline in intellectual abilities, with a high tendency to develop neuropathological features associated with Alzheimer's disease [1,2].”
BackgroundNerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome
Iulita, M. F., & Cuello, A. C. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.010 · Cited by 141
Gauthier, S. A., Pérez‐González, R., Sharma, A., Huang, F.-K., Alldred, M. J., Pawlik, M., Kaur, G., Ginsberg, S. D., Neubert, T. A., & Levy, E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0466-0 · Cited by 125
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome
Contestabile, A., Magara, S., & Cancedda, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00054 · Cited by 141
“DS patients and Ts65Dn mice demonstrate increased incidence of epileptic seizures (Stafstrom et al., 1991; Westmark et al., 2010; Rissman and Mobley, 2011; Lott, 2012; Robertson et al., 2015).”
BackgroundAziz, N. M., Guedj, F., Pennings, J. L. A., Olmos-Serrano, J. L., Siegel, A., Haydar, T. F., & Bianchi, D. W. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031013 · Cited by 118
“…to identify suitable models for basic and translational studies (Bahado-Singh et al., 1992; Cardoso et al., 2015; Guidi et al., 2008; Haim et al., 2009; Larsen et al., 2008; Lott, 2012; Nilholm, 1999; Vicari et al., 2013; Winter et al., 1998; Wisniewski and Kida, 1994; Wisniewski et al., 1984).”
BackgroundButterfield, D. A., Domenico, F. D., Swomley, A. M., Head, E., & Marzia Perluigi, A. (2014) · Biochemical Journal · doi:10.1042/bj20140772 · Cited by 112
Gardiner, K. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s51476 · Cited by 119
“Antioxidants Oxidative stress and mitochondrial dysfunction are both considered hallmarks of DS tissues and contributors to neurological phenotypes across the DS lifespan.(1,91) Cortical neurons derived from DS fetal brains show elevated levels of reactive oxygen species, and survival is enhanced by treatment with ant…”
InfluentialNeurologic complications of Down syndrome: a systematic review
Santoro, J. D., Pagarkar, D., Chu, D. T., Rosso, M., Paulsen, K. C., Levitt, P. R., & Rafii, M. S. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10179-w · Cited by 119
Iulita, M. F., Ower, A., Barone, C., Pentz, R., Gubert, P., Romano, C., Cantarella, R. A., Elia, F., Buono, S., Recupero, M., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.05.001 · Cited by 99
“All r moderate-to-severe intellectual disability from early life and cognitive decline with advancing age [1,2].”
BackgroundKumar, S., Wirths, O., Theil, S., Gerth, J., Bayer, T. A., & Walter, J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1107-8 · Cited by 101
García-Cerro, S., Rueda, N., Vidal, V., Lantigua, S., & Martínez-Cué, C. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.010 · Cited by 100
“Down syndrome (DS) is the most common genetic cause of intellectual disability (Shin et al., 2009) and is primarily caused by prenatal changes in central nervous system growth and differentiation (Lott, 2012; Haydar and Reeves, 2012).”
BackgroundDomenico, F. D., Pupo, G., Tramutola, A., Giorgi, A., Schininà, M. E., Coccia, R., Head, E., Butterfield, D. A., & Marzia Perluigi, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.027 · Cited by 98
“In addition to cognitive deficits, individuals with DS show signs of premature aging, immune disorders, and other clinical pathologies [6].”
BackgroundRETRACTED AND REPLACED: Nerve growth factor metabolic dysfunction in Down’s syndrome brains
Iulita, M. F., Carmo, S. D., Ower, A. K., Fortress, A. M., Aguilar, L. F., Hanna, M., Wısnıewskı, T., Granholm, A., Buhusi, M. C., Busciglio, J. A., et al. (2014) · Brain · doi:10.1093/brain/awt372 · Cited by 94
“It is well established that individuals with Down’s syndrome are at increased risk of developing premature ageing and Alzheimer’s disease dementia (Lott, 2012).”
RetractedFrontal white matter integrity in adults with Down syndrome with and without dementia
Powell, D. K., Caban‐Holt, A., Jicha, G. A., Robertson, W. C., Davis, R., Gold, B. T., Schmitt, F. A., & Head, E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.137 · Cited by 90
“The most common cause of Down syndrome (DS) is triplication of chromosome 21, resulting in a phenotype that is accompanied by altered brain development and other neurologic features (Lott, 2012).”
Age-Related Changes of Adaptive and Neuropsychological Features in Persons with Down Syndrome
Ghezzo, A., Salvioli, S., Solimando, M. C., Palmieri, A., Chiostergi, C., Scurti, M., Lomartire, L., Bedetti, F., Cocchi, G., Follo, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113111 · Cited by 86
Franceschi, C., Garagnani, P., Gensous, N., Bacalini, M. G., Conte, M., & Salvioli, S. (2019) · Aging Cell · doi:10.1111/acel.12903 · Cited by 82
“able of taking into account the clinical heterogeneity of DS persons, particularly when they grow old (Lott, 2012).”
BackgroundInfluentialDi Domenico, F., Pupo, G., Mancuso, C., Barone, E., Paolini, F., Arena, A., Blarzino, C., Schmitt, F. A., Head, E., Butterfield, D. A., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141254 · Cited by 75
“Oxidative damage is also an early event in DS and might contribute to the development of deleterious DS phenotypes, including abnormal brain development and AD [3] [4] [5] [6].”
Sarkis, R. A., Dickerson, B. C., Cole, A. J., & Chemali, Z. N. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15060143 · Cited by 75
“Future analysis of this particular subpopulation of patients with dementia and seizures is of interest because of the high prevalence of AD pathology after age 40 years and new-onset epilepsy.(25) A subset of patients (13%) had the occurrence of their seizures either preceding or occurring within 1 year of their cogni…”
BackgroundBrain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Tramutola, A., Lanzillotta, C., Di Domenico, F., Head, E., Butterfield, D. A., Perluigi, M., & Barone, E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104772 · Cited by 73
“This aspect appears of interest due to the observation that DS brain morphology continue to diverge compared with typically developing individuals (Lott, 2012).”
Aging with Down Syndrome—Where Are We Now and Where Are We Going?
Alldred, M. J., Martini, A. C., Patterson, D., Hendrix, J. A., & Granholm, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204687 · Cited by 72
Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues
Belichenko, P. V., Kleschevnikov, A. M., Becker, A., Wagner, G. E., Lysenko, L. V., Yu, Y. E., & Mobley, W. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134861 · Cited by 73
“We conclude that the TTS mouse demonstrates a number of motor phenotypes that are similar to those in DS [100], but different from the corresponding phenotypes observed in other mouse DS models.”
ResultNew approaches to studying early brain development in Down syndrome
Baburamani, A. A., Patkee, P. A., Arichi, T., & Rutherford, M. A. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14260 · Cited by 74
“Other techniques, such as the neurite orientation distribution and density imaging model can also provide measures of the neurite density index and orientation dispersion index which may help explore the cortical synaptic and dendritic developmental abnormalities that are widely reported in Down syndrome.(9,41) Althou…”
BackgroundMethodSynaptophysin and Synaptojanin-1 in Down Syndrome are Differentially Affected by Alzheimer's Disease
Martin, S. B., Dowling, A. L. S., Lianekhammy, J., Lott, I. T., Doran, E., Murphy, M. P., Beckett, T. L., Schmitt, F. A., & Head, E. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140795 · Cited by 64
“The gene for SYNJ1 is on chromosome 21 and present in triplicate in DS [21].”
Self-citationTyrer, F., Dunkley, A. J., Singh, J., Kristunas, C., Khunti, K., Bhaumik, S., Davies, M. J., Yates, T. E., & Gray, L. J. (2018) · Journal of Intellectual Disability Research · doi:10.1111/jir.12571 · Cited by 67
Neuroimaging assessment in Down syndrome: a pictorial review
Rodrigues, M., Nunes, J., Figueiredo, S., de Campos, A. M., & Geraldo, A. F. (2019) · Insights into Imaging · doi:10.1186/s13244-019-0729-3 · Cited by 60
Kaur, G., Sharma, A., Xu, W., Gerum, S., Alldred, M. J., Subbanna, S., Basavarajappa, B. S., Pawlik, M., Ohno, M., Ginsberg, S. D., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5338-13.2014 · Cited by 58
“To date, the mechanism(s) underlying these intellectual disabilities and age-related cognitive decline in DS is unclear, although data suggest that a wide array of neurochemical changes may compromise cognitive performance in DS (Cataldo et al., 2000; Lott, 2012).”
BackgroundImpact of increased APP gene dose in Down syndrome and the Dp16 mouse model
Sawa, M., Overk, C., Becker, A., Derse, D., Albay, R., Weldy, K., Salehi, A., Beach, T. G., Doran, E., Head, E., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12463 · Cited by 54
Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism
Barone, E., Arena, A., Head, E., Butterfield, D. A., & Marzia Perluigi, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.009 · Cited by 55
“DS individuals, after the age of 40, develop a type of dementia that is similar to AD, the most common cause of dementia in the elderly population, with deposition of senile plaques containing amyloid beta-peptide (Aβ), neurofibrillary tangles (NFTs) composed of hyperphoshorylated tau, and cholinergic and serotonergic…”
BackgroundRole of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease
Potter, H., Granic, A., & Caneus, J. (2015) · Current Alzheimer Research · doi:10.2174/156720501301151207100616 · Cited by 54
“This finding provided the first direct evidence that three copies of the APP gene alone are sufficient to yield earlyonset, fully penetrant familial AD, although it is noteworthy that some people with trisomy 21 DS appear to be protected from developing AD dementia, despite having AD neuropathology [3].”
Sensory Processing and Maladaptive Behavior: Profiles Within the Down Syndrome Phenotype
Will, E., Daunhauer, L. A., Fidler, D. J., Lee, N., Rosenberg, C. R., & Hepburn, S. (2019) · Physical & Occupational Therapy In Pediatrics · doi:10.1080/01942638.2019.1575320 · Cited by 53
“Hypotonia (i.e., low muscle tone; for a review see Lott, 2012), for example, is characteristic to DS and speculated to affect attainment of motor milestones and other areas of development (Fidler et al., 2011).”
BackgroundPonroy Bally, B., Farmer, W. T., Jones, E. V., Jessa, S., Kacerovsky, J. B., Mayran, A., Peng, H., Lefebvre, J. L., Drouin, J., Hayer, A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa003 · Cited by 49
Lanzillotta, C., Tramutola, A., Di Giacomo, G., Marini, F., Butterfield, D. A., Di Domenico, F., Perluigi, M., & Barone, E. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.042 · Cited by 47
The rise and fall of insulin signaling in Alzheimer’s disease
Chami, B., Steel, A. J., de la Monte, S. M., & Sutherland, G. T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9806-1 · Cited by 48
Kleschevnikov, A. M., Yu, J., Kim, J., Lysenko, L. V., Zeng, Z., Yu, Y. E., & Mobley, W. C. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.009 · Cited by 49
“…are cognitive and behavioral impairments in children and the emergence of Alzheimer’s disease in the elderly (Belichenko et al., 2016; Dierssen, 2012; Dykens, 2007; Kleschevnikov et al., 2012c; Lott, 2012; Nadel, 2003; Roizen and Patterson, 2003; Roper and Reeves, 2006; Sabbagh and Edgin, 2016).”
BackgroundIGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome
Araya, P., Kinning, K. T., Coughlan, C., Smith, K. P., Granrath, R. E., Enriquez-Estrada, B. A., Worek, K., Sullivan, K. D., Rachubinski, A. L., Wolter-Warmerdam, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111883 · Cited by 50
GIRK Channels Mediate the Nonphotic Effects of Exogenous Melatonin
Hablitz, L. M., Molzof, H. E., Abrahamsson, K. E., Cooper, J. M., Prosser, R. A., & Gamble, K. L. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1597-15.2015 · Cited by 44
Stem and progenitor cell dysfunction in human trisomies
Liu, B., Filippi, S., Roy, A., & Roberts, I. A. G. (2014) · EMBO Reports · doi:10.15252/embr.201439583 · Cited by 44
“2007 [199]; Lott 2012 [18]; Lockrow et al.”
InfluentialBlock, A., Ahmed, M. M., Dhanasekaran, A. R., Tong, S., & Gardiner, K. J. (2015) · Biology of Sex Differences · doi:10.1186/s13293-015-0043-9 · Cited by 43
“Of particular importance, now that the life span of people with DS has increased to >60 years, is the universal development of the pathology of AD by age 30 and the development in half of those with DS of an AD-like dementia by the age of 50 [27].”
BackgroundLanguage Development in Individuals With Intellectual and Developmental Disabilities
(2016) · International Review of Research in Developmental Disabilities · doi:10.1016/bs.irrdd.2016.05.006 · Cited by 43
Estimates of the prevalence of speech and motor speech disorders in adolescents with Down syndrome
Wilson, E. M., Abbeduto, L., Camarata, S., & Shriberg, L. D. (2019) · Clinical Linguistics & Phonetics · doi:10.1080/02699206.2019.1595735 · Cited by 42
“The presence of generalized hypotonia in individuals with DS is well-documented in the literature (Lott, 2012) and reportedly plays a role in delayed motor skill acquisition; however, a conclusive causal association between hypotonia and delayed motor development in children with DS has not been…”
Marzia Perluigi, A., Tramutola, A., Pagnotta, S. E., Barone, E., & Butterfield, D. A. (2020) · Antioxidants · doi:10.3390/antiox9090779 · Cited by 44
Modeling Neurodevelopmental Disorders Using Human Pluripotent Stem Cells
Telias, M., & Ben‐Yosef, D. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9507-2 · Cited by 43
“Down syndrome (DS) is the most common form of intellectual disability, with the affected individuals having an average IQ of 50 [160–163].”
Dissecting Alzheimer disease in Down syndrome using mouse models
Choong, X. Y., Tosh, J., Pulford, L. J., & Fisher, E. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00268 · Cited by 41
“…although this can be difficult to determine, particularly as DS has been characterized as a syndrome of accelerated aging in both clinical (Lott, 2012; Zigman, 2013) and epigenetic terms (Horvath et al., 2015), and because aging remains the clearest non-genetic risk factor for all forms…”
Backgroundvan den Bemd, M., Schalk, B. W. M., Bischoff, E. W. M. A., Cuypers, M., & Leusink, G. L. (2022) · Family Practice · doi:10.1093/fampra/cmac042 · Cited by 44
Alzheimer's Disease Modeling: Ups, Downs, and Perspectives for Human Induced Pluripotent Stem Cells
Wojda, U., & Kuźnicki, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121984 · Cited by 40
Alldred, M. J., Chao, H. M., Lee, S. H., Beilin, J., Powers, B. E., Petkova, E., Strupp, B. J., & Ginsberg, S. D. (2018) · Hippocampus · doi:10.1002/hipo.22832 · Cited by 35
“DS is also the primary genetic cause of intellectual disability (ID), with cognitive deficits in hippocampal-dependent learning and memory, attention, and language and communication skills (Chapman & Hesketh, 2000; Esbensen, 2010; Lott, 2012; Rachidi & Lopes, 2008, 2010).”
BackgroundThe Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice
Lumaban, J. G., & Nelson, D. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu737 · Cited by 36
Alldred, M. J., Lee, S. H., Stutzmann, G. E., & Ginsberg, S. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.707950 · Cited by 34
“…and basal forebrain cholinergic neuron (BFCN) degeneration, with the accompanying cognitive decline, typically by the mid-third decade of life (Mann et al., 1984; Coyle et al., 1988; Beacher et al., 2009; Lott and Dierssen, 2010; Costa, 2012; Lott, 2012; Hartley et al., 2015; Annus et al., 2016).”
BackgroundSoy Infant Formula and Seizures in Children with Autism: A Retrospective Study
Westmark, C. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080488 · Cited by 34
Netrin‐1 induces local translation of down syndrome cell adhesion molecule in axonal growth cones
Jain, S., & Welshhans, K. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22360 · Cited by 33
“Nevertheless, our findings can be considered in the context of the Down syndrome human brain phenotype, which includes reduced neuronal connectivity (Wang et al., 1992; Teipel et al., 2003; Gotti et al., 2011; Lott, 2012).”
BackgroundDementia in intellectual disability
Sheehan, R., Ali, A., & Hassiotis, A. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000032 · Cited by 33
“The neuropathology underlying the association of Down syndrome with dementia is not clear, although triplication of genes on chromosome 21, including the amyloid precursor protein (APP) gene, has been implicated [8].”
BackgroundWu, C.-I., Vinton, E. A., Pearse, R. V., Heo, K., Aylward, A. J., Hsieh, Y., Bi, Y., Adeleye, S., Fancher, S. B., Duong, D. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01454-5 · Cited by 33
Deutsch, S. I., Burket, J. A., & Benson, A. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.05.011 · Cited by 34
Dashinimaev, E. B., Artyuhov, A., Bolshakov, A. P., Vorotelyak, E. A., & Vasiliev, A. V. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160945 · Cited by 32
Obstructive sleep apnoea/hypopnoea syndrome in adults with Down syndrome
Hill, E. A. (2016) · Breathe · doi:10.1183/20734735.012116 · Cited by 32
“These deficits are related to structural and functional changes within the brain, some present from birth and others, such as plaques and tangles associated with dementia, acquired over time [5–7].”
Dumortier, L., & Bricout, V. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.018 · Cited by 33
Modeling epileptic spasms during infancy: Are we heading for the treatment yet?
Velı́šek, L., & Velı́šková, J. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107578 · Cited by 31
“Finally, the model does not provide age-specificity while in patients with trisomy 21, IS occur only during infancy and later different types of seizures prevail (Beatty, et al., 2017; Lott, 2012).”
MethodNew Perspectives for the Rescue of Cognitive Disability in Down Syndrome
Bartesaghi, R., Haydar, T. F., Delabar, J. M., Dierssen, M., Martínez‐Cué, C., & Bianchi, D. W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2775-15.2015 · Cited by 32
Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice
Rueda, N., Vidal, V., García-Cerro, S., Narcís, J. O., Llorens-Martı́n, M., Corrales, A., Lantigua, S., Iglesias, M., Merino, J., Merino, R., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.008 · Cited by 31
“This intellectual disability is primarily caused by prenatal changes in central nervous system growth and differentiation (Lott, 2012; Haydar and Reeves, 2012).”
BackgroundAging With Down Syndrome: The Dual Diagnosis: Alzheimer’s Disease and Down Syndrome
Cipriani, G., Danti, S., Carlesi, C., & Fiorino, M. D. (2018) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317518761093 · Cited by 32
Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer’s disease
Ivanov, S. M., Atanasova, M., Dimitrov, I., & Doytchinova, I. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-67119-x · Cited by 29
Iulita, M. F., Caraci, F., & Cuello, A. C. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160321104916 · Cited by 28
Incontinence in persons with Down Syndrome
Niemczyk, J., von Gontard, A., Equit, M., Medoff, D., Wagner, C., & Curfs, L. (2016) · Neurourology and Urodynamics · doi:10.1002/nau.23146 · Cited by 28
“In DS, neuroanatomic alterations (reduced brain weight, smaller volumes of hippocampus, temporal lobes, and cerebellum) and histological findings (decreased number of neurons, neuronal density, neuronal distribution, and synaptic density) support the hypothesis of an abnormal neuronal connectivity.(21) It can be hypot…”
Kazim, S. F., Blanchard, J., Bianchi, R., & Iqbal, K. (2017) · Scientific Reports · doi:10.1038/srep45561 · Cited by 28
“This process ultimately leads to recognition memory, which consists of two components: (1) familiarity, a global awareness of the features of a stimulus, and (2) recollection, knowledge of the stimulus in the context of other information, such as what, where, or under which context the stimulus was encountered115–118.”
BackgroundSoriano, L. D. H., Thurman, A. J., & Abbeduto, L. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00424 · Cited by 28
“Indeed, the cognitive and behavioral pattern described for DS in the current study might differ dramatically at a later age as a consequence of their high risk of developing the neuropathology associated wi9th Alzheimer’s Disease and the resulting dementia-like symptoms (Lott, 2012).”
BackgroundMartínez‐Cué, C., & Rueda, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186906 · Cited by 26
“The cognitive alterations found in DS are primarily caused by prenatal changes in central nervous system (CNS) growth and differentiation [3,4].”
BackgroundLondon, J., Rouch, C., Bui, L. C., Assayag, E., Souchet, B., Daubigney, F., Medjaoui, H., Luquet, S. H., Magnan, C., Delabar, J. M., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0591-6 · Cited by 29
Measuring Health-Related Quality of Life of Adults With Down Syndrome
Graves, R., Graff, J. C., Esbensen, A. J., Hathaway, D., Wan, J. Y., & Wicks, M. N. (2016) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-121.4.312 · Cited by 26
Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan
LeVine, H., Spielmann, H. P., Matveev, S., Cauvi, F. M., Murphy, M. P., Beckett, T. L., McCarty, K. L., Lott, I. T., Doran, E. W., Schmitt, F. A., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.005 · Cited by 26
“Down syndrome (DS) or trisomy 21 is the most common genetic cause of intellectual disability and is associated with a neurologic phenotype that includes the development of AD neuropathology by the age of 40 years (Head et al., 2016; Lott, 2012; Lott and Dierssen, 2010).”
BackgroundSelf-citationCôté, V., Lalancette, È., Knoth, I. S., Côté, L., Agbogba, K., Vannasing, P., Major, P., Barlaam, F., Michaud, J. L., & Lippé, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147205 · Cited by 25
Gholipour, T., Mitchell, S. B., Sarkis, R. A., & Chemali, Z. N. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.12.014 · Cited by 25
Treatment Considerations for Obstructive Sleep Apnea in Pediatric Down Syndrome
Gastelum, E., Cummins, M., Singh, A., Montoya, M. J., Urbano, G. L., & Tablizo, M. A. (2021) · Children · doi:10.3390/children8111074 · Cited by 24
“Generalized hypotonia is nearly universal in children with DS [11].”
BackgroundAge‐Related Cortical Thickness Reduction in Non‐Demented Down's Syndrome Subjects
Romano, A., Cornia, R., Moraschi, M., Bozzao, A., Chiacchiararelli, L., Coppola, V., Iani, C., Stella, G., Albertini, G., & Pierallini, A. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12259 · Cited by 25
Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome
Lee, S. E., Duran-Martinez, M., Khantsis, S., Bianchi, D. W., & Guedj, F. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.10.001 · Cited by 25
“All individuals with DS exhibit significant hypoplasia of the frontal lobe, hippocampus, and cerebellum, and mild to severe intellectual disability [2, 3].”
BackgroundGenetic and Epigenetic Mechanisms in Down Syndrome Brain
Lu, J., & Shee, V. (2013) · InTech eBooks · doi:10.5772/52807 · Cited by 24
“Several HSA21 genes have been implicated in generation of ROS including DYRK1A, DSCR1, SOD1, ETS2, S100B, APP and BACH1 [15, 17].”
BackgroundDopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders
Ijomone, O. K., Oria, R. S., Ijomone, O. M., Aschner, M., & Bornhorst, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04418-8 · Cited by 22
“Such deficiencies are linked to neuroanatomical problems such as decreased brain weight and size, delayed lamination, and aberrant dendritic and spine formation [167, 168].”
Lysenko, L. V., Kim, J., Madamba, F., Tyrtyshnaia, A. A., Ruparelia, A., & Kleschevnikov, A. M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.005 · Cited by 21
“Down syndrome (DS) is the most common genetic cause of intellectual disability in children and adults (Chapman and Hesketh, 2000; Dierssen, 2012; Gardiner et al., 2010; Lott, 2012; Roizen and Patterson, 2003; Wiseman et al., 2009).”
BackgroundGene Expression Studies in Down Syndrome: What Do They Tell Us about Disease Phenotypes?
Chapman, L., Ramnarine, I. V. P., Zemke, D., Majid, A., & Bell, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052968 · Cited by 23
“These manifest as hypotonia at birth, abnormal gait, ligamentous laxity, seizures, intellectual disability and early neuropathological changes in Alzheimer’s disease (often by 40 years old) [49].”
BackgroundSoriano, L. D. H., Thurman, A. J., Harvey, D. J., Kover, S. T., & Abbeduto, L. (2020) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-020-09320-7 · Cited by 21
“For example, the observed changes with age aimed to vary with the nature of the disability might differ dramatically at a later age as a consequence of the high risk of developing the neuropathology associated with Alzheimer’s disease and the resulting dementia-like symptoms for those with DS [119].”
BackgroundAbukhaled, Y., Hatab, K., Awadhalla, M., & Hamdan, H. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11890-0 · Cited by 30
“As for neurological system , it is important to consider 3 different categories: neurodevelopmental, psychotic, and neurological [12].”
BackgroundDay, S. M., Yang, W., Wang, X., Stern, J. E., Zhou, X., Macauley, S. L., & Ma, T. (2019) · eNeuro · doi:10.1523/eneuro.0031-19.2019 · Cited by 21
“Impaired cognition is a hallmark of DS, and there are currently no effective treatments that improve cognitive function in individuals with DS (Patterson, 2009; Lana-Elola et al., 2011; Lott, 2012).”
BackgroundMitsogiannis, M. D., Pancho, A., Aerts, T., Sachse, S., Vanlaer, R., Noterdaeme, L., Schmucker, D., & Seuntjens, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.624181 · Cited by 22
“Given the reduced cell number and anomalous neuronal organization observed within specific neocortex regions and layers of DS brains already at mid-to-late gestational stages (Colon, 1972; Becker et al., 1991; Golden and Hyman, 1994; Haydar and Reeves, 2012; Lott, 2012), we sought to examine the effects of Dscam and D…”
BackgroundInfluentialGiannasi, L. C., Politti, F., Dutra, M. T. D. S., Tenguan, V. L. S., Silva, G. R. C., de Mancilha, G. P., da Silva, D. B., de Oliveira, L. V. F., Oliveira, C. S., Amorim, J. B. O., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63963-z · Cited by 20
Down Syndrome, Ageing and Epigenetics
Gensous, N., Franceschi, C., Salvioli, S., Garagnani, P., & Bacalini, M. G. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_7 · Cited by 19
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
Caraci, F., Iulita, M. F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., & Cuello, A. C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.004 · Cited by 18
Hair Mineral and Trace Element Content in Children with Down’s Syndrome
Grabeklis, A. R., Skalny, A. V., Skalnaya, A. A., Zhegalova, I. V., Notova, S. V., Mazaletskaya, A. L., Геннадиевна, С. М., & Tinkov, A. A. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1506-8 · Cited by 18
Metadata
- Authors
- Lott, I. T.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Lott, Ira T.
- ORCID
- Lott, Ira T.
- Venue
- Progress in Brain Research
- Publisher
- Elsevier
- Published
- 2012
- Volume
- 197
- Pages
- 101-121
- ISSN
- 0079-6123 (ISSN-L)
- PMC
- PMC3417824
- OpenAlex
- W1829879414
- Cited by
- 225
- References
- 163
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 13 · 2023: 14 · 2022: 19 · 2021: 22 · 2020: 21 · 2019: 14 · 2018: 15 · 2017: 18 · 2016: 13 · 2015: 17 · 2014: 22 · 2013: 10 · 2012: 3
- FWCI
- 38.75
- Type
- book chapter
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Progress in brain research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG 21912, P50AG016573, R01AG021912)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD065160, HD 37427, HD-065160, R01HD037427)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Down syndrome, neurological phenotype, intellectual disability, brain circuits, hypotonia, infantile spasms, seizures, Alzheimer's disease, dementia, chromosome 21 genes, amyloid-beta, neurodegeneration, glucose metabolism, mitochondrial dysfunction, oxidative stress, sleep apnea, thyroid metabolism, behavioral problems, mouse model, synaptic plasticity, aging
- MeSH terms
- Age Factors, Aging, Brain, Cognition Disorders, Down Syndrome, Humans, Muscle Hypotonia, Nervous System Diseases, Phenotype, Amyloid beta-Peptides, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review